Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 53.31
ILS 4798.26ILS 53.31
ILS 639.44
60 tablet
Free AirMail shipping Hot
ILS 56.87
ILS 3412.05ILS 56.87
ILS 213.09
30 tablet
Free AirMail shipping Hot
ILS 60.42
ILS 1812.57ILS 60.42
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 63.98
ILS 5757.95ILS 63.98
ILS 319.54
60 tablet
Free AirMail shipping Hot
ILS 65.75
ILS 3945.21ILS 65.75
ILS 106.45
30 tablet
Free AirMail shipping Hot
ILS 67.53
ILS 2025.83ILS 67.53
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 76.42
ILS 6877.59ILS 76.42
ILS 319.54
60 tablet
Free AirMail shipping Hot
ILS 78.19
ILS 4691.63ILS 78.19
ILS 106.45
30 tablet
Free AirMail shipping Hot
ILS 79.97
ILS 2399.04ILS 79.97
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.